RoslinCT is a contract manufacturing organisation focused on providing tailored process development services and robust GMP manufacturing solutions for companies developing cell-based therapeutics for clinical trials.
Supporting you at every step of your advanced therapy journey.
15 February 2021
RoslinCT - a cell and gene therapy/ATMP Contract Development and Manufacturing Organization (CDMO) – announces the establishment of the RoslinCT Training Academy. The fitting out of the Academy, which is located within our new state of the art facility, is progressing well and will focus on upskilling existing staff as well as providing external training as part of the UK Advanced Therapies Skills Training Network.
25 June 2020
RoslinCT - a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) - announces initiation of construction for the expansion of their new manufacturing centre. This expansion accelerates our development and manufacturing capability, promising to bring next-generation treatments to patients globally.
26 March 2019
RoslinCT is a leading Contract Development and Manufacturing Organisation (CDMO), offering a range of integrated services from technology transfer, process and assay development through to GMP manufacturing, storage, QP certification and batch release of cell-based therapies for clinical trials.
01:15 pm Feb 15th
We are delighted to announce the establishment of the RoslinCT Training Academy. The Cell and Gene Training Academy… https://t.co/AK1RucGS2z
01:20 pm Feb 11th
Today is the International Day of Women and Girls in Science and at RoslinCT we're celebrating all the fantastic wo… https://t.co/0mmOJR2h5R
02:37 pm Feb 5th
We can't believe is February 2021 already! Looking back to the challenging 2020 we are proud of what we achieved an… https://t.co/hGoZbVTdhI